Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Catecholamine release in human heart by bupropion.

Bodo Cremers1, Kathrin I Schmidt, Christoph Maack

  • 1Medizinische Klinik und Poliklinik, Innere Medizin III, Universitätskliniken des Saarlandes, 66421 Homburg, Germany. cremers@med-in.uni-sb.de

European Journal of Pharmacology
|April 23, 2003
PubMed
Summary

Bupropion, a smoking cessation aid, shows positive inotropic effects on human heart muscle. This suggests bupropion has indirect sympathomimetic activity, likely through catecholamine release.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In the era of AI, omics and organoids, animal models are still needed in cardiovascular research.

Nature reviews. Cardiology·2026
Same author

RBM20 variants disrupt Ca<sup>2+</sup> handling and metabolism in dilated and non-compaction cardiomyopathy stem cell models.

Signal transduction and targeted therapy·2026
Same author

[Advancing cardiovascular prevention : Evidence-based design of healthy and sustainable food environments].

Herz·2026
Same author

[Heart and climate].

Herz·2026
Same author

Peroxisomal catalase and plasmalogen biosynthesis protect from oxidative stress in Barth syndrome cardiomyopathy.

Basic research in cardiology·2026
Same author

[Noise and the heart].

Herz·2026

Area of Science:

  • Pharmacology
  • Cardiology
  • Physiology

Background:

  • Limited data exists on the specific cardiac effects of bupropion, a non-nicotine smoking cessation pharmacotherapy.
  • The direct impact of bupropion on human myocardial contractility remains largely unknown.
  • Understanding bupropion's cardiac actions is crucial for patient safety during smoking cessation therapy.

Purpose of the Study:

  • To investigate the in vitro effects of bupropion on human cardiac tissue.
  • To determine if bupropion directly influences myocardial contractility.
  • To elucidate the mechanism behind bupropion's cardiac effects.

Main Methods:

  • Human cardiac tissue samples were utilized for in vitro experimentation.
  • The effects of bupropion on myocardial contractility were assessed.

Related Experiment Videos

  • Mechanisms, including catecholamine release, were explored.

    • Main Results:

    • Bupropion demonstrated positive inotropic effects on human myocardium.
    • The study suggests bupropion possesses indirect sympathomimetic activity.
    • Catecholamine release is indicated as the probable mechanism for these effects.

    Conclusions:

    • Bupropion exerts a positive inotropic effect on human myocardium.
    • This effect is likely mediated by indirect sympathomimetic activity via catecholamine release.
    • Further research into bupropion's cardiac electrophysiology and long-term effects is warranted.